HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mevalonate kinase deficiency syndrome with structural damage responsive to anakinra.

AuthorsT Lequerré, O Vittecoq, S Pouplin, N Klemmer, O Mejjad, A Daragon, A M Prieur, X Le Loët
JournalRheumatology (Oxford, England) (Rheumatology (Oxford)) Vol. 46 Issue 12 Pg. 1860-2 (Dec 2007) ISSN: 1462-0332 [Electronic] England
PMID17965046 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Interleukin 1 Receptor Antagonist Protein
Topics
  • Adult
  • Arthritis (drug therapy, etiology, physiopathology)
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Female
  • Follow-Up Studies
  • Humans
  • Interleukin 1 Receptor Antagonist Protein (therapeutic use)
  • Mevalonate Kinase Deficiency (complications, diagnosis)
  • Pain Measurement
  • Recovery of Function
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: